SynthesisBMC public health2025
Lassa fever in West Africa: a systematic review and meta-analysis of attack rates, case fatality rates and risk factors.
Synthesis in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Adjuvanted inactivated rabies virus-vectored Lassa virus vaccine in healthy adults: a phase 1 trial.Nature medicine · 2026Trial
- Article
- Global Cross-Border Migration and Secondary Transmission Patterns of Lassa Fever - Global, 1969-2025.China CDC weekly · 2026Article
- A fractional-order analysis of recurrent Lassa fever transmission in Nigeria.Virus research · 2026Article
- Zoonotic disease knowledge, attitudes, and livestock biosecurity practices among community members in Ada East District, Ghana: a concurrent mixed-methods study.One health outlook · 2026Article
- Serological evidence of Lassa virus in commensal rodents from Senegal.BMC infectious diseases · 2026Article
- Local heterogeneity in Lassa fever serology in rural Nigeria: Implications for vaccine trial site selection.PLoS neglected tropical diseases · 2026Article
- Climate-driven changes in zoonotic risk of arenaviral hemorrhagic fevers in South America.Npj viruses · 2026Article
- Mapping the scientific landscape of Lassa virus: a 55-year bibliometric study (1970-2025).Science in One Health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLassa fever is an acute viral haemorrhagic disease endemic to West Africa, with Nigeria, Sierra Leone, and Liberia bearing the greatest burden. Despite repeated outbreaks and rising incidence, a regional synthesis of epidemiologic indicators remains lacking. This systematic review and meta-analysis aimed to estimate pooled attack rates (proportion of a population affected during an outbreak), case fatality rates (CFRs), and identify consistent risk factors associated with Lassa fever in West Africa.
methodsFollowing PRISMA 2020 guidelines, we systematically searched PubMed, Scopus, AJOL, and Web of Science for observational studies published between 1969 and 2025. Eligible studies reported attack rates, CFRs, or risk factors for Lassa fever among human populations. Only English-language, peer-reviewed studies were included and included study quality was assessed using the Newcastle-Ottawa Scale. Data were analyzed using random-effects meta-analysis. Heterogeneity was assessed using the I² statistic, and subgroup analyses were conducted by country, diagnostic method, study design, and setting.
resultsOut of 333 identified studies, thirty-five studies were included. The pooled attack rate was 21.0% (95% CI: 18.0%-24.0%, I² = 98.6%) and CFR was 27.0% (95% CI: 20.0%-35.0%, I² = 99.4%), with significant heterogeneity. Subgroup analysis showed higher CFRs in Sierra Leone (48%) and Liberia (40%) compared to Nigeria (16%). Cohort studies and hospital-based settings reported markedly higher attack rates and CFRs. RT-PCR-based diagnostics were associated with lower CFRs than serological or mixed-method studies. The pooled odds ratio for risk factors was 1.29 (95%CI: 1.10-1.49), with environmental exposures (rodent infestation, poor housing) having the strongest association (OR = 2.18). Evidence also pointed to a shift in disease transmission from rural to peri-urban settings, driven by urbanization, habitat loss, and climate change.
conclusionLassa fever continues to pose a severe public health threat in West Africa, characterized by high transmission, elevated mortality, and evolving ecological dynamics. To reduce morbidity and mortality, integrated strategies are needed such as early diagnosis via decentralized RT-PCR, environmental hygiene, risk communication, and vaccine preparedness within a One Health framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.